Rheumatoid arthritis is treated with a combination of medications that slow joint damage, therapies that preserve mobility, and in some cases surgery. The cornerstone of treatment is starting disease-modifying drugs as early as possible, ideally within the first few months of diagnosis, because joint damage that occurs early on can’t be reversed. Most people will use several treatment approaches at once, and the specific mix changes over time based on how well the disease responds.
Disease-Modifying Drugs: The Foundation
The most important category of RA medication is disease-modifying antirheumatic drugs, commonly called DMARDs. Unlike painkillers, which only mask symptoms, DMARDs slow or stop the immune system from attacking your joints. This prevents the progressive erosion of cartilage and bone that leads to deformity and disability over years.
Methotrexate is the first drug most people with RA are prescribed. It’s taken just once a week, typically starting at 7.5 mg and gradually increasing up to 20 mg in tablet form or 25 mg by self-injection if needed. It works by dialing down the overactive immune response driving the inflammation. You won’t feel results immediately. Methotrexate takes about 4 to 6 weeks to start working, and improvements can continue building over several months. Other conventional DMARDs include hydroxychloroquine (2 to 4 months to take effect), sulfasalazine (6 weeks to 3 months), and leflunomide (4 to 8 weeks).
If methotrexate alone isn’t controlling your symptoms well enough, your rheumatologist will typically add a second medication rather than simply switch, building a more aggressive regimen over time.
Biologics: Targeted Immune Therapy
Biologics represent a newer, more precisely targeted class of treatment. Where conventional DMARDs broadly suppress immune activity, biologics zero in on specific proteins or cells that drive inflammation. They’re usually added when conventional DMARDs haven’t brought the disease under adequate control.
The largest group is TNF inhibitors, which block a protein called tumor necrosis factor, one of the key signals that triggers joint inflammation. These can work relatively fast, with some people noticing improvement within 2 to 4 weeks, though additional gains continue over 3 to 6 months. Other biologics target different parts of the immune system: some block inflammatory messengers called interleukins (IL-1, IL-6, or IL-17), while others deplete a type of white blood cell called B cells that contributes to the autoimmune attack. B-cell-targeting drugs take longer to kick in, with effects sometimes not appearing for up to 3 months after an infusion. Another option works by interrupting the communication between immune cells, with responses typically seen within 3 months.
Most biologics are given as self-injections at home every one to four weeks, or as infusions at a clinic. They’re almost always used alongside methotrexate, which boosts their effectiveness.
JAK Inhibitors: A Pill-Based Alternative
A newer option for people who haven’t responded well to other treatments is a class of oral medications called JAK inhibitors. Three are currently approved for RA: tofacitinib, baricitinib, and upadacitinib. Unlike biologics, which are large molecules that need to be injected, JAK inhibitors are small-molecule drugs taken as daily pills. They work by blocking enzymes inside immune cells that relay inflammatory signals.
The FDA has added warnings to all three about increased risks of serious heart-related events, cancer, blood clots, and death compared to TNF inhibitors. Because of this, they’re generally reserved for people who haven’t responded to or can’t tolerate other treatments, particularly TNF inhibitors.
Short-Term Relief While Waiting for DMARDs
Because DMARDs take weeks or months to work, you’ll likely need something to manage pain and swelling in the meantime. Corticosteroids like prednisone are commonly used as a bridge during this gap. Doses for RA are typically low, around 5 to 10 mg daily, and the goal is always to use the smallest effective dose for the shortest time necessary. Long-term steroid use carries significant side effects including bone thinning, weight gain, and increased infection risk, so your doctor will taper you off as your DMARD begins working.
Nonsteroidal anti-inflammatory drugs (NSAIDs) also provide quick symptom relief but don’t slow joint damage. They’re useful for managing day-to-day pain and stiffness, particularly morning stiffness, while the disease-modifying drugs build up in your system.
Physical and Occupational Therapy
Medication controls the disease, but therapy helps you maintain function. A physical therapist can teach you which movements place excessive stress on inflamed joints and guide you through range-of-motion exercises that keep joints flexible without aggravating them. Learning to recognize which activities trigger pain and fatigue, and then modifying those activities, is a core skill that protects your joints over time. Resting locally inflamed joints during flares is also important for recovery.
Occupational therapy focuses on practical independence. This might mean learning joint protection techniques, like using larger joints to carry loads instead of smaller finger joints, or getting fitted for orthotic devices. Custom foot orthotics and properly fitted shoes can significantly reduce pain during walking and standing. Ankle-foot braces help prevent joint contractures and support weakened muscles. For hands, simple adaptive tools make a real difference: utensils with built-up handles, plate guards, zipper pulls, velcro straps to replace buttons, and strap-on cuffs that hold items like a toothbrush when grip strength is limited.
When Surgery Becomes Necessary
Joint replacement surgery is considered only after non-surgical approaches have been given a reasonable chance and haven’t been successful. It’s typically recommended for people with advanced, end-stage joint disease where significant structural damage has already occurred. The decision isn’t based solely on what imaging shows. How much the joint damage is affecting your quality of life, your ability to function day to day, and the level of disabling pain all factor heavily into whether surgery makes sense.
The joints most commonly replaced in RA are knees, hips, and sometimes shoulders or knuckles. Smaller procedures, like tendon repair, may be an option for damage caught earlier. With modern medical treatment starting earlier and working better than it did a generation ago, fewer people with RA ultimately need surgery, but it remains an important option when joint destruction has progressed beyond what medication can manage.
How Treatment Is Adjusted Over Time
RA treatment follows a “treat to target” philosophy. Your rheumatologist will set a specific goal, usually low disease activity or remission, and adjust medications every few months until you reach it. If methotrexate alone isn’t enough after 3 to 6 months, a biologic or second conventional DMARD gets added. If that combination isn’t working, you’ll switch to a different biologic class or try a JAK inhibitor. This stepwise escalation continues until the disease is adequately controlled.
Once you reach remission or low disease activity and maintain it for a sustained period, your doctor may cautiously reduce medications, sometimes tapering biologics first while keeping methotrexate as a maintenance therapy. Complete drug-free remission is possible for some people but uncommon. Most will need some level of ongoing treatment to keep the disease quiet and prevent flares from causing new joint damage.